Alanna Strong

3.2k total citations · 1 hit paper
47 papers, 1.3k citations indexed

About

Alanna Strong is a scholar working on Molecular Biology, Genetics and Surgery. According to data from OpenAlex, Alanna Strong has authored 47 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 22 papers in Genetics and 10 papers in Surgery. Recurrent topics in Alanna Strong's work include Renal and related cancers (7 papers), Genetic and Kidney Cyst Diseases (6 papers) and Genetic Syndromes and Imprinting (5 papers). Alanna Strong is often cited by papers focused on Renal and related cancers (7 papers), Genetic and Kidney Cyst Diseases (6 papers) and Genetic Syndromes and Imprinting (5 papers). Alanna Strong collaborates with scholars based in United States, Israel and Canada. Alanna Strong's co-authors include Daniel J. Rader, Kevin Patel, Kiran Musunuru, Qiurong Ding, Chad A. Cowan, Sze‐Ling Ng, Bridget S. Gosis, Ethan M. Goldberg, Dennis Dlugos and David Bearden and has published in prestigious journals such as Journal of Clinical Investigation, Circulation Research and Annals of Neurology.

In The Last Decade

Alanna Strong

41 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Permanent Alteration of PCSK9 With In Vivo CRISPR-Cas9 Genome Editing

2014 402 citations Alanna Strong, Daniel J. Rader et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alanna Strong United States	13	721	319	303	229	146	47	1.3k
Anne Fougerat France	14	578 0.8×	248 0.8×	98 0.3×	70 0.3×	128 0.9×	21	1.0k
Sizhong Zhang China	23	887 1.2×	626 2.0×	216 0.7×	83 0.4×	52 0.4×	111	1.8k
Felicity Newell Australia	16	795 1.1×	243 0.8×	91 0.3×	62 0.3×	108 0.7×	29	1.3k
Yuri Ivashchenko United States	16	953 1.3×	115 0.4×	105 0.3×	142 0.6×	84 0.6×	17	1.4k
Nathalie Danièle France	18	742 1.0×	136 0.4×	154 0.5×	139 0.6×	159 1.1×	27	1.1k
Earl Lawrence United States	12	733 1.0×	164 0.5×	95 0.3×	80 0.3×	401 2.7×	14	1.5k
Christopher L. Pin Canada	23	919 1.3×	232 0.7×	583 1.9×	51 0.2×	204 1.4×	54	1.7k
Miho Kimura Japan	18	479 0.7×	120 0.4×	82 0.3×	117 0.5×	50 0.3×	37	1.3k
Meral Özgüç Türkiye	20	1.0k 1.4×	173 0.5×	193 0.6×	32 0.1×	291 2.0×	55	1.6k
Yuan-Yuan Ho Hong Kong	12	325 0.5×	275 0.9×	83 0.3×	64 0.3×	44 0.3×	18	785

Countries citing papers authored by Alanna Strong

Since Specialization

Citations

This map shows the geographic impact of Alanna Strong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alanna Strong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alanna Strong more than expected).

Fields of papers citing papers by Alanna Strong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alanna Strong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alanna Strong. The network helps show where Alanna Strong may publish in the future.

Co-authorship network of co-authors of Alanna Strong

This figure shows the co-authorship network connecting the top 25 collaborators of Alanna Strong. A scholar is included among the top collaborators of Alanna Strong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alanna Strong. Alanna Strong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Strong, Alanna, Caoimhe McKenna, Karen Stals, et al.. (2025). Truncating Variants in RREB1 Cause a Novel RASopathy Syndrome of Congenital Heart Disease, Genitourinary Malformations, and Developmental Delay. American Journal of Medical Genetics Part A. 197(10). e64119–e64119. 1 indexed citations

Gold, Jessica A., et al.. (2025). A New EP300‐Related Syndrome With Prominent Developmental and Immune Phenotypes. American Journal of Medical Genetics Part A. 197(8). e64050–e64050.

Cohen, Jennifer L., Michael Duyzend, Mark D. Fleming, et al.. (2025). Advancing precision care in pregnancy through a treatable fetal findings list. The American Journal of Human Genetics. 112(6). 1251–1269.

Gold, Nina B., et al.. (2025). Are Inherited Metabolic Disorders More Common and Less Predictable Than We Thought?. Journal of Inherited Metabolic Disease. 48(6). e70094–e70094.

Strong, Alanna, Michael March, Christopher J. Cardinale, et al.. (2024). Novel insights into the phenotypic spectrum and pathogenesis of Hardikar syndrome. Genetics in Medicine. 26(10). 101222–101222. 2 indexed citations

Zoltick, Emilie S., Hana Zouk, Emma Perez, et al.. (2024). Long‐Term Health Outcomes of Individuals With Pseudodeficiency Alleles in IDUA May Inform Newborn Screening Practices for Mucopolysaccharidosis Type I. American Journal of Medical Genetics Part A. 197(4). e63940–e63940.

Hong, Xinying, et al.. (2023). Combined PMM2-CDG and hereditary fructose intolerance in a patient with mild clinical presentation. Molecular Genetics and Metabolism. 140(3). 107682–107682. 1 indexed citations

Gold, Jessica I., Sarina Madhavan, Joseph Park, et al.. (2023). Phenotypes of undiagnosed adults with actionable OTC and GLA variants. Human Genetics and Genomics Advances. 4(4). 100226–100226. 2 indexed citations

Strong, Alanna, Hui‐Qi Qu, Sinéad Cullina, et al.. (2023). TOPORS as a novel causal gene for Joubert syndrome. American Journal of Medical Genetics Part A. 191(8). 2156–2163. 2 indexed citations

10.

Strong, Alanna, Jisun Kim, Deborah Watson, et al.. (2022). TBX6 as a cause of a combined skeletal‐kidney dysplasia syndrome. American Journal of Medical Genetics Part A. 188(12). 3469–3481. 8 indexed citations

11.

Clark, Robin D., Jamie L. Fraser, Alanna Strong, et al.. (2022). Delayed diagnosis and racial bias in children with genetic conditions. American Journal of Medical Genetics Part A. 188(4). 1118–1123. 17 indexed citations

12.

Strong, Alanna, Anthony D. Krentz, Deborah Watson, et al.. (2021). Expanding the genetic landscape of oral‐facial‐digital syndrome with two novel genes. American Journal of Medical Genetics Part A. 185(8). 2409–2416. 11 indexed citations

13.

Strong, Alanna, Gina O’Grady, Jonathan Bishop, et al.. (2021). A new syndrome of moyamoya disease, kidney dysplasia, aminotransferase elevation, and skin disease associated with de novo variants in RNF213. American Journal of Medical Genetics Part A. 185(7). 2168–2174. 11 indexed citations

14.

Strong, Alanna, Michael March, Christopher J. Cardinale, et al.. (2021). A novel MBTPS2 variant associated with BRESHECK syndrome impairs sterol‐regulated transcription and the endoplasmic reticulum stress response. American Journal of Medical Genetics Part A. 188(2). 463–472. 4 indexed citations

15.

Strong, Alanna, Dong Li, Frank Mentch, & Håkon Håkonarson. (2021). A novel heterotaxy gene: Expansion of the phenotype of TTC21B‐spectrum disease. American Journal of Medical Genetics Part A. 185(4). 1266–1269. 5 indexed citations

16.

Strong, Alanna, Cara Skraban, Kevin Meyers, et al.. (2021). Expanding the phenotypic spectrum of Mendelian connective tissue disorders to include prominent kidney phenotypes. American Journal of Medical Genetics Part A. 185(12). 3762–3769. 1 indexed citations

17.

Strong, Alanna, Dong Li, Frank Mentch, et al.. (2020). Ciliopathies: Coloring outside of the lines. American Journal of Medical Genetics Part A. 185(3). 687–694. 7 indexed citations

18.

Strong, Alanna, et al.. (2018). Isosorbide dinitrate in nephronophthisis treatment. American Journal of Medical Genetics Part A. 176(4). 1023–1026. 4 indexed citations

19.

Strong, Alanna & Kiran Musunuru. (2016). Genome editing in cardiovascular diseases. Nature Reviews Cardiology. 14(1). 11–20. 61 indexed citations

20.

Strong, Alanna & Daniel J. Rader. (2012). Sortilin as a Regulator of Lipoprotein Metabolism. Current Atherosclerosis Reports. 14(3). 211–218. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact